Abstract
Transitional cell carcinoma of the ovary is a rare variant of epithelial ovarian cancers(EOC).It has been described as a primary ovarian carcinoma with definite urothelial features but no benign, metaplastic and/or proliferating Brenner tumor (BT) identified. Recognition of such tumors is important because of its rarity, favorable response to chemotherapy and an improved patient survival. Treatment comprised multimodality approach using surgery, chemotherapy and radiotherapy. Surgery remains the mainstay of the treatment of this variant of EOC. Postoperative adjuvant radiotherapy improved local control in patients with adverse prognostic factors. Adjuvant radiotherapy improves outcome in patients with adverse factors.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
